Chemical Genomics

    About       Membership     Newsfeed        Events           Press     

 

John S. Dunn Gulf Coast Consortium for Chemical Genomics

Putting Gulf Coast investigators ahead of the game in making groundbreaking drug advances and exciting new genome insights.


When the John S. Dunn Gulf Coast Consortium for Chemical Genomics (GCC CG) was organized in 2003, many Gulf Coast institution research laboratories were engaged in screening projects, but they were generally too small to be effective. To reduce the duplication of effort and to expand the screening capabilities, the GCC CG was organized as a research consortium to bring together scientists interested in this area of research with the aim of developing an inter-institutional academic drug discovery program.

The GCC CG’s Screening Lab and Satellite Facilities include the latest automation equipment for assay development and advanced central screening laboratories.


Upcoming Events:

Chemical Genomics Symposium, November 1-2, 2018


 
The Texas Screening Alliance for Cancer Therapeutics organizes and operates a multi-institutional research consortium that provides Texas’ cancer researchers with access to expertise and high-throughput technologies critical for drug discovery research. To achieve these aims the TxSACT Program has assembled a team of outstanding scientists in a multi-institutional consortium, organized under the auspices of the Gulf Coast Consortia. By increasing the capacity and the accessibility of academic drug discovery research, the new TxSCAT Program is aligned with CPRIT’s mission to “create and expedite innovation in the area of cancer research, thereby enhancing the potential for a medical or scientific breakthrough in the prevention of cancer and cures for cancer.” TxSACT is funded by a Multi-Investigator Research Award from the Cancer Prevention and Research Institute of Texas.